Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2023 Dec 7;16(12):e254775. doi: 10.1136/bcr-2023-254775

Multiple micronutrient deficiencies as a long-term complication of bariatric surgery

Devika Dixit 1, Vanessa I Rodriguez 2,✉, Ashton A Naumann 3, Amir Y Kamel 4
PMCID: PMC10711813  PMID: 38061845

Abstract

Micronutrient deficiencies may develop as a long-term complication of bariatric surgery due to alteration of gut anatomy and disruption of normal gut absorption. Inadequate repletion of essential vitamin and mineral deficiencies can lead to multisystem dysfunction. We present a case of a woman in her 50s, with a history of Roux-en-Y gastric bypass over 10 years ago, who presented with generalised weakness and a diffuse desquamating rash. A punch biopsy performed was compatible with nutritional deficiency. Labs revealed low levels of micronutrients A, B1, B6, C, E, zinc and copper. The patient received intravenous micronutrients and an oral regimen, which improved her symptoms. Unfortunately, the patient died from cardiac arrest secondary to pulmonary oedema. This report highlights the importance of high suspicion of micronutrient deficiency in patients with a history of bariatric surgery and maintaining lifelong nutritional follow-up.

Keywords: Gastroenterology, Gastrointestinal surgery, Dermatology, Nutrition and metabolism, Malnutrition

Background

Obesity is steadily on the rise among the US adult population, likely reaching 51% of the adult population by 2030.1 Bariatric surgery is effective in treating morbidly obese patients and improves obesity-associated comorbidities. Common procedures include gastric bypass, sleeve gastrectomy and biliopancreatic diversion. Roux-en-Y gastric bypass (RYGB) is the most prevalent globallt.1 However, one of the consequences of bariatric surgeries is that it causes or exacerbates nutritional deficiencies.2 Mechanisms that explain why bariatric surgery leads to nutritional deficiencies include alteration to the intestinal anatomy and gut microbial environment as well as dysregulation of enzymes and hormones.3

Most studies on nutritional deficiencies after gastric bypass examine deficiencies of vitamin B12, vitamin B9, vitamin D, calcium and iron.4–12 For instance, one systematic review and meta-analysis of 46 studies found folate and B12 as the most prevalent deficiencies with their longest follow-up being 6 years after RYGB surgery.5 However, some studies have investigated other micronutrient deficiencies such as vitamin A, vitamin E, selenium and zinc.13–15 A review of 82 studies found vitamin A and E deficiencies ≥24 months after RYGB surgery.13 One review that looked at nine studies found a prevalence of 16% of selenium deficiency at 1-year follow-up.14 While another systematic review concluded that clinically relevant zinc deficiency is rare and routine monitoring may be unnecessary.15 Nevertheless, few studies have looked at follow-up >10 years after RYGB. One review of 34 studies reported a prevalence of 54% of secondary hyperparathyroidism >10 years after RYGB.9 Our case is unique as it presents a patient with various micronutrient deficiencies >10 years after RYGB.

Nutritional deficiencies can manifest as skin lesions, weakness, nausea, vomiting, diarrhoea, anaemia, ataxia, hair loss and Wernicke’s encephalopathy.16 However, these manifestations can be misinterpreted as symptoms of other illnesses, such as autoimmune or malignant diseases. Arriving at a diagnosis of micronutrient deficiency can be done by comprehensively understanding the medical and surgical history of the patient. Therefore, there should be a high suspicion of micronutrient deficiencies in patients with a history of bariatric surgery and multiple systemic symptoms (ie, ataxia, rash, anaemia, diarrhoea).

Case presentation

A woman in her 50s with a history of RYGB over 10 years prior to admission (surgery report of the RYGB was not available due to lack of documentation from outside hospital), gallstone pancreatitis, cirrhosis of unknown aetiology, hypertension, diabetes mellitus type 2, hypothyroidism and stress-induced cardiomyopathy with normal ejection fraction presented to the emergency room with 1 week of worsening generalised weakness as well as a diffuse, pruritic and painful desquamating rash. The patient endorsed a 13.6 kg weight loss with nausea, abdominal pain, diarrhoea, loss of taste, arthralgias and chills over the past 3 weeks. Patient’s dietary history or supplement intake prior to admission was not available. She did not have a fever, recent trauma or mucosal involvement of rash. She denied a history of similar rash, immunocompromised state, new environmental exposures, recent travel or insect bites.

The patient was hospitalised 2 months prior to admission for Campylobacter jejuni gastroenteritis, which may have occurred due to small intestinal bacterial overgrowth (SIBO). However, it is also possible that the patient acquired a gastrointestinal (GI) infection from something she ate as the patient reported eating at several other restaurants prior to her presentation. Nevertheless, the patient does not have a history of GI issues and her workup for her diarrhoea only demonstrated a GI PCR positive for C. jejuni and a normal CRP and procalcitonin.

On presentation, the patient was afebrile with a blood pressure of 80/55 mm Hg, heart rate of 99 beats/min and oxygen saturation of 98% on room air. The patient’s body mass index was 20.36 kg/m2. Physical examination was notable for dry mucous membranes and generalised abdominal tenderness to palpation without peritonitic signs. A superficial desquamating rash was noted on the bilateral upper and lower extremities, upper back and lower abdomen with areas of superficial erosion on bilateral antecubital fossa (figure 1).

Figure 1.

Figure 1

Before and after nutritional supplementation.

Initial laboratory tests were suggestive for sepsis, including elevated procalcitonin, lactic acid and C reactive protein as well as elevated glucose and thyroid-stimulating hormone (TSH) (table 1). However, there were findings of poor medication compliance for the patient’s underlying hypothyroidism and diabetes mellitus type 2, explaining the intense hyperglycaemia and changes in the thyroid hormones on admission. Imaging was significant for moderate volume ascites, anasarca and edematous appearance of the small and large bowel with mild stranding and wall thickening. The patient was admitted for management of sepsis, weakness and a desquamating rash of unknown aetiology.

Table 1.

Index hospitalisation laboratory values

Laboratory tests Laboratory values Reference range
Procalcitonin 5.03 ng/mL <0.1 ng/mL
Lactic acid 6.2 mmol/L 0.3–1.5 mmol/L
C reactive protein 23 mg/L 0–5 mg/L
Total creatine kinase 73 U/L <420 U/L
White cell count 4.0×109 /L 4.0–10.0×109 /L
Haemoglobin 125 g/L 130–165 g/L
Platelets 185×109 /L 150–450×109 /L
Albumin 2.7 g/dL 3.5–5.2 g/dL
International normalized ratio (INR) 1.3 0.8–1.1
Aspartate aminotransferase 19 IU/L 0–37 IU/L
Alanine transaminase 60 IU/L 0–35 IU/L
Alkaline phosphatase 171 IU/L 33–133 IU/L
Glucose 416 mg/dL 65–99 mg/dL
Thyroid-stimulating hormone (TSH) 31 mIU/L 0.4–5.0 mIU/L
T4 0.66 ng/dL 0.6–1.20 ng/dL
Vitamin A 0.09 mg/L 0.30–1.20 mg/L
Vitamin B1 70 nmol/L 70–180 nmol/L
Vitamin B3 5.02 µg/mL 0.50–8.45 µg/mL
Vitamin B6 11.1 nmol/L 20–125 nmol/L
Vitamin B9 >20.0 ng/mL >5.8 ng/mL
Vitamin B12 >1500 pg/mL 180–914 pg/mL
Vitamin C 40 µmol/L 20–114 µmol/L
Vitamin E 3.5 mg/L 5.5–18.0 mg/L
Zinc 33.5 µg/dL 60–120 µg/dL
Copper 35.8 µg/dL 80–155 µg/dL
Total protein 5.8 g/dL 6.4–8.3 g/dL
Prealbumin Undetectable 20–40 mg/dL
Albumin 2.7 g/dL 3.5–5.2 g/dL
Tissue transglutaminase <2 U/mL 0–3 U/mL
Antinuclear antibodies IgG <1:80 <1:80
Anti-double stranded DNA IgG <1:10 <1:10
C3 complement 45 mg/dL 87–200 mg/dL
C4 complement 16 mg/dL 13–50 mg/dL
Anticardiolipin IgG <9.4 U/mL ≤20 GPL U/mL
Anti-smith IgG 2 units 2 units 0–19 units
Lyme disease Ab/total with reflex 0.37 IV ≤0.9 IV
HIV fourth-generation antigen/antibody Negative Negative
Syphilis treponemal antibodies Negative Negative
Nucleic acid amplification for Chlamydia Trachomatis Negative Negative
Nucleic acid amplification for Neisseria Gonorrhoeae Negative Negative

Investigations

Infectious workup revealed blood cultures that were positive for methicillin-resistant Staphylococcus aureus for which intravenous antibiotic was initiated. A transthoracic echocardiogram showed no evidence of vegetation. Dermatology was consulted for the skin rash, and they recommended a punch biopsy as well as obtaining micronutrient levels due to concerns for nutritional deficiency. Punch biopsy was compatible with nutritional deficiency showing confluent parakeratosis and necrotic keratinocytes scattered throughout the epidermis and areas of slight dysmaturation as evident by suprabasal mitoses. Vitamins A, B1, B6, C and E as well as zinc, copper, and proteins were deficient (table 1). Pancreatic elastase was <10 (less than 100 μg/g is severe insufficiency) and faecal fat was normal. Given her diarrhoea, a GI PCR panel was ordered and showed no organisms. Burn surgery was consulted and recommended no surgical intervention. Wound specialists were also consulted, and they provided wound care recommendations, such as daily barrier ointments.

Differential diagnosis

Our differential diagnosis was initially expansive given the patient’s non-specific presentation. Autoimmune aetiologies were considered given the patient’s sex, arthralgias, diffuse rash and fatigue. Systemic lupus erythematosus (SLE) was considered; however, antinuclear antibodies IgG, antidouble-stranded DNA, IgG, anticardiolipin IgG, anti-smith IgG and C4 complement were within reference range (table 1). The patient’s C3 complement was low, but the most sensitive and specific tests were used to rule out SLE. In addition, she did not present with common symptoms such as mouth ulcers, malar rash, chest pain, kidney disease and fevers. Further evaluating autoimmune causes of the patient’s rash, coeliac disease was considered because it can affect nutrient absorption resulting in micronutrient deficiencies. However, it was ruled out using tissue transglutaminase, which was within reference range (table 1).

Infectious aetiologies, such as Lyme disease, rocky mountain spotted fever and staphylococcal scalded skin syndrome, were considered. The patient denied new environmental exposures, recent travel, or insect bites. Lyme disease testing was negative (table 1). Sexually transmitted diseases with cutaneous manifestations were considered, particularly HIV, disseminated gonococcal syndrome, syphilis and Chlamydia trachomatis. Laboratory tests were performed and unremarkable (table 1).

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome was considered; however, the patient denied starting a new medication 2–8 weeks before presentation. She did not take any medications that are frequently associated with DRESS syndrome such as antiseizure medications, allopurinol or antibiotics. In addition, she did not have characteristic features such as eosinophilia, atypical lymphocytosis, acute hepatocellular injury, worsening renal function or lymphadenopathy.

Refeeding syndrome (RFS) is an essential consideration since the patient had unintentional weight loss and little or no nutritional intake. Hypophosphataemia, hypokalaemia and hypomagnesaemia should raise suspicion of RFS, but were absent in this case. Precautions were taken to ensure the patient would not develop RFS when initiating diet, such as monitoring laboratory values and slowly starting nutritional repletion. Patients with RFS may present with symptoms ranging from nausea, lethargy to respiratory failure, arrhythmias and death. However, the patient’s symptoms initially improved in response to the intensive nutrition regimen without electrolyte derangements, therefore, excluding the diagnosis.17

In addition, the patient’s serum reductions of several micronutrients may be due to the patient’s recent episode of possible SIBO. However, she did not have the common vitamin deficiencies seen in SIBO such as vitamins B12 and D.18 In this case, micronutrient deficiencies are likely due to altered anatomy from RYGB leading to altered absorption as well as the patient’s reduced oral intake.

Treatment

A nutrition support team was consulted, and her nutrition deficiencies were managed with daily intravenous vitamin transfusions, which included zinc chloride 30 mg, copper chloride 4000 μg, vitamin B9 1 mg, vitamin B1 500 mg, vitamin B6 100 mg and vitamin C 1000 mg. Daily oral vitamin D3 50 μg, vitamin A capsule 20 000 units and vitamin E capsule 450 mg were provided. Weekly oral vitamin D2 capsule 1.25 mg and multivitamin tablet were provided. Zinc oxide 40% paste and vitamin A cream were applied at least two times per day. Additionally, oral supplementation included protein supplementation shakes three times per day. There was a concern that she had malabsorption of fat-soluble vitamins secondary to exocrine pancreatic insufficiency, so she was also started on pancrelipase three times per day.

The patient did not receive oral replacement therapy for some nutrient deficiencies because there was a concern of malabsorption early on in the admission due to the patient’s low-normal citrulline level of 23. Citrulline is a biomarker for malabsorption. Therefore, we did not pursue oral repletion and repleted intravenously.

Outcome and follow-up

During the patient’s admission, her symptoms initially improved in response to the intensive nutrition regimen described previously. For instance, the patient’s rash became less diffuse, erythematous and desquamating, with the return of the patient’s original skin tone (figure 1). Also, the patient’s appetite and oral intake increased, and diarrhoea improved. Her admission continued for another few weeks due to the need for intravenous antibiotics, nutrition supplementation and need for intermittent vasopressors. Unfortunately, a month into her admission she developed refractory hypotension and was transitioned to the intensive care unit where she was found to have pulmonary oedema. She died shortly after from cardiac arrest related to pulmonary oedema, despite resuscitation efforts.

Discussion

Restrictive-malabsorptive procedure

Bariatric surgery alters gastric and intestinal anatomy leading to defective nutritional absorption. Therefore, many patients are susceptible to micronutrient deficiencies. RYGB is a restrictive-malabsorptive procedure that isolates a small functional pouch at the top of the stomach that directly connects to the jejunum, allowing food to bypass most of the stomach and the entire duodenum.19 The procedure is considered both restrictive and malabsorptive. It results in a significant reduction in the surface area of the stomach and duodenum, which reduces the amount of nutrition absorbed.20 Trace metals, such as iron, calcium, magnesium and zinc, are absorbed in the duodenum, which is completely bypassed leading to metal deficiencies.21

The procedure is malabsorptive because nutrients are not exposed to fluids that allow nutrients to be absorbed by the small intestine. For instance, nutrients are not exposed to bile which is excreted from the ampulla of Vater in the duodenum. Bile acids are essential for the absorption of lipophilic molecules including fats and fat-soluble vitamins A, D, E and K. In RYGB patients, bile does not encounter food until the food reaches the distal jejunum.22 Therefore, patients with RYGB may become deficient in fat-soluble vitamins and fats. Water-soluble vitamins, such as vitamins B12, B1, C and B9, have also been shown to be at risk for deficiency in patients with gastric bypass.19 For instance, RYGB impairs vitamin B12 metabolism by affecting gastric acid production, therefore, affecting the release of vitamin B12 from cobalamin-R-binding proteins and decreased production of intrinsic factor.

Clinical manifestations of micronutrient deficiencies

Our case exhibits a rare presentation of vitamin, mineral and protein deficiencies with correlating clinical symptoms:

Fat-soluble vitamin deficiencies

Fat-soluble vitamins include vitamins A, D, E and K. The patient in our case had vitamin A and E deficiencies. Vitamin A deficiency presents with acne, dry hair, fatigue, growth impairment, insomnia, hyperkeratosis, immune impairment, night blindness and weight loss.23 The patient presented with hyperkeratosis (revealed in skin biopsy), immune impairment and weight loss. Vitamin A deficiency in bariatric patients has shown to be resistant to supplementation.23 Studies have demonstrated prophylactic supplementation of vitamin A did not prevent deficiency after distal RYGB for 10% of patients after 4 years.24

Vitamin E deficiency manifests as gait disturbances, poor reflexes, loss of position sense, loss of vibration sense and shortened red blood cell life.23 This patient experienced gait disturbances on presentation. Vitamin E deficiency is not common in bariatric surgery patients.23 For instance, a study showed serum vitamin E levels were normal in patients at 1 year and remained normal in 96% of the patients up to 4 years after bariatric surgery.25 However, the patient had surgery more than 10 years ago, demonstrating possible long-term depleting effects of RYGB on vitamin E stores.

Water-soluble vitamin deficiencies

Water-soluble vitamins include B vitamins and vitamin C. Thiamine, or vitamin B1, deficiency can lead to confusion, constipation, digestive problems, irritability, loss of appetite, memory loss, nervousness, numbness of hands and feet, poor coordination, and weakness.23 This patient experienced symptoms of diffuse upper and lower extremities weakness, poor gait, diffuse abdominal pain, impaired appetite and anxiety which correlated with vitamin B1 deficiency.

Vitamin B6 can cause anaemia, arthritis, depression, dizziness, impaired wound healing, excessive tearing, angular palpebritis, conjunctiva, angular cheilitis, hypertrophied papillae, irritability, loss of appetite, mouth lesions and nausea.23 The patient presented with several symptoms of vitamin B6 deficiency, including impaired appetite and anaemia.

After bariatric surgery, the incidence of vitamin B1 and B6 deficiencies are reportedly low.23 One study found only 29 cases of thiamine deficiency out of 168 010 cases of bariatric surgeries.26 Most studies show clinical symptoms of thiamine deficiency within 2–3 months of bariatric surgery. However, our case demonstrates manifestations of thiamine deficiency over a decade after surgery.23

Mineral deficiencies

In addition to vitamin deficiencies, this patient had zinc and copper deficiencies. Zinc deficiency presents with acne, amnesia, apathy, brittle nails, depression, diarrhoea, eczema, fatigue, growth impairment, hair loss, hair colour changes, loss of appetite, loss of sense of taste, low stomach acid, nail deformity, immune deficiencies, upper respiratory infections, decubitus ulcers, eye lesions, night blindness and wound healing impairment.23 This patient presented with loss of appetite and immune deficiencies. Zinc deficiency is common among bariatric patients, so supplementation and monitoring is recommended.

Copper deficiency presents as anaemia, neutropenia, leucopenia, pancytopenia, depression, diarrhoea, fatigue, fragile bones, hair loss, weakness, altered pigmentation of the skin, hypothermia, reduced resistance to infections, cardiomyopathy, connective tissue breakdown and neurological symptoms (polyneuropathy, paresthesia, myelopathy).23 Out of all these symptoms, this patient had leucopenia, fatigue, skin texture changes, skin pigmentation, weakness and a rash. Interestingly, copper deficiency has not been widely reported in bariatric patients.

Protein deficiency

Protein deficiency manifests as hypoalbuminaemia, anaemia, oedema, asthenia, delayed wound healing, wasted appearance and alopecia.23 The patient demonstrated most aspects of protein deficiency, for instance, she had hypoalbuminaemia and low levels of total protein (table 1). Additionally, the patient had anaemia with a haemoglobin of 125 g/L (normal: 130–165 g/L).

Lastly, this patient displayed upper and lower extremity oedema and asthenia. RYGB patients experience protein deficiency for various reasons, such as poor oral intake and malabsorption. Protein deficiency is a common complication of RYGB. In fact, at a minimum of 2 years after RYGB surgery, 13% of the patients were found to have hypoalbuminemia and required parenteral nutrition for severe protein malnutrition.24

To summarise, the patient’s complicated hospital course was attributed to her severe malnutrition. The development of her rash was likely due to vitamin A deficiency and copper and zinc deficiencies increased her susceptibility to infections. During the admission, she developed refractory hypotension despite being on multiple pressors, which was likely secondary to cardiogenic shock. She died from cardiac arrest related to pulmonary edema. The patient’s evolution to death could have also occurred due to worsening of her underlying stress-induced cardiomyopathy as her body was under significant stress. By screening as recommended by the American Society for Metabolic and Bariatric Surgery, micronutrient deficiencies can be detected in a timely manner, thus preventing more serious complications, including death.27

Learning points

  • Certain vitamin and mineral deficiencies may manifest multiple years after bariatric surgery.

  • Patients may need lifelong broad vitamin, mineral and protein supplementation as deficiencies can occur years after bariatric surgery.

  • Clinical manifestations of nutritional deficiencies are non-specific and may present similarly to other diseases, prolonging diagnosis.

  • Deficiencies may be further exacerbated in the setting of inadequate oral intake, changes in intestinal absorption over time, poor access to healthcare and medication non-compliance.

Footnotes

Contributors: DD, VIR, AAN and AYK jointly conceived the idea for the case report. DD was primarily responsible for writing the manuscript. VIR and AAN helped with background research and assisted with writing the manuscript. AYK assisted with writing the manuscript, provided subject matter expertise and is responsible for its final content.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Ethics statements

Patient consent for publication

Not applicable.

References

  • 1.Alalwan AA, Friedman J, Alfayez O, et al. Drug absorption in bariatric surgery patients: a narrative review. Health Sci Rep 2022;5:e605. 10.1002/hsr2.605 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Bal BS, Finelli FC, Shope TR, et al. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol 2012;8:544–56. 10.1038/nrendo.2012.48 [DOI] [PubMed] [Google Scholar]
  • 3.Seyfried F, Hoffmann A, Rullmann M, et al. Weight loss from caloric restriction vs Roux-en-Y gastric bypass surgery differentially regulates systemic and portal vein Gdf15 levels in obese zucker fatty rats. Physiol Behav 2021;240:113534. 10.1016/j.physbeh.2021.113534 [DOI] [PubMed] [Google Scholar]
  • 4.Weng TC, Chang CH, Dong YH, et al. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open 2015;5:e006964. 10.1136/bmjopen-2014-006964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nunes R, Santos-Sousa H, Vieira S, et al. Vitamin B complex deficiency after Roux-en-Y gastric bypass and sleeve gastrectomy-a systematic review and meta-analysis. Obes Surg 2022;32:873–91. 10.1007/s11695-021-05783-2 [DOI] [PubMed] [Google Scholar]
  • 6.Kwon Y, Ha J, Lee Y-H, et al. Comparative risk of anemia and related micronutrient deficiencies after Roux-en-Y gastric bypass and sleeve gastrectomy in patients with obesity: an updated meta-analysis of randomized controlled trials. Obes Rev 2022;23:e13419. 10.1111/obr.13419 [DOI] [PubMed] [Google Scholar]
  • 7.Enani G, Bilgic E, Lebedeva E, et al. The incidence of iron deficiency anemia post-Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review. Surg Endosc 2020;34:3002–10. 10.1007/s00464-019-07092-3 [DOI] [PubMed] [Google Scholar]
  • 8.Cabral JAV, Souza G de, Nascimento J de A, et al. Impact of vitamin d and calcium deficiency in the bones of patients undergoing bariatric surgery: a systematic review. Arq Bras Cir Dig 2016;29(Suppl 1):120–3. 10.1590/0102-6720201600S10029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gao Z, Liang Y, Zheng C, et al. Prevalence and associated factors of secondary hyperparathyroidism after Roux-en-Y gastric bypass: a meta-analysis. Obes Rev 2022;23:e13488. 10.1111/obr.13488 [DOI] [PubMed] [Google Scholar]
  • 10.Majumder S, Soriano J, Louie Cruz A, et al. Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis 2013;9:1013–9. 10.1016/j.soard.2013.04.017 [DOI] [PubMed] [Google Scholar]
  • 11.Cui Y, Zhang D, Wang L, et al. Which nutritional prognosis is better? Comparison of the three most commonly performed bariatric surgeries: a systematic review and network meta-analysis. Front Surg 2022;9:1065715. 10.3389/fsurg.2022.1065715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mahawar KK, Reid A, Graham Y, et al. Oral vitamin B12 supplementation after Roux-en-Y gastric bypass: a systematic review. Obes Surg 2018;28:1916–23. 10.1007/s11695-017-3102-y [DOI] [PubMed] [Google Scholar]
  • 13.Ha J, Kwon Y, Kwon J-W, et al. Micronutrient status in bariatric surgery patients receiving postoperative supplementation per guidelines: insights from a systematic review and meta-analysis of longitudinal studies. Obes Rev 2021;22:e13249. 10.1111/obr.13249 [DOI] [PubMed] [Google Scholar]
  • 14.Shahmiri SS, Eghbali F, Ismaeil A, et al. Selenium deficiency after bariatric surgery, incidence and symptoms: a systematic review and meta-analysis. Obes Surg 2022;32:1719–25. 10.1007/s11695-022-05932-1 [DOI] [PubMed] [Google Scholar]
  • 15.Mahawar KK, Bhasker AG, Bindal V, et al. Zinc deficiency after gastric bypass for morbid obesity: a systematic review. Obes Surg 2017;27:522–9. 10.1007/s11695-016-2474-8 [DOI] [PubMed] [Google Scholar]
  • 16.Gasmi A, Bjørklund G, Mujawdiya PK, et al. Micronutrients deficiences in patients after bariatric surgery. Eur J Nutr 2022;61:55–67. 10.1007/s00394-021-02619-8 [DOI] [PubMed] [Google Scholar]
  • 17.Khan LUR, Ahmed J, Khan S, et al. Refeeding syndrome: a literature review. Gastroenterol Res Pract 2011;2011:410971. 10.1155/2011/410971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zaidel O, Lin HC. Uninvited guests: the impact of small intestinal bacterial overgrowth on nutritional status. Pract Gastroenterol 2003;27:27–33. [Google Scholar]
  • 19.Seeras K, Acho RJ, Lopez PP. Roux-en-Y gastric bypass chronic complications. [Updated 2022 Jun 11]. Treasure Island (FL): StatPearls Publishing, 2022. Available: https://www.ncbi.nlm.nih.gov/books/NBK519489/ [PubMed] [Google Scholar]
  • 20.Ruz M, Carrasco F, Rojas P, et al. Zinc absorption and zinc status are reduced after either sleeve gastrectomy or Roux-en-Y gastric bypass in premenopausal women with severe obesity studied prospectively over 24 postoperative months. Am J Clin Nutr 2021;114:322–9. 10.1093/ajcn/nqab039 [DOI] [PubMed] [Google Scholar]
  • 21.Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition 2010;26:1031–7. 10.1016/j.nut.2009.12.003 [DOI] [PubMed] [Google Scholar]
  • 22.Pizzorno L. Bariatric surgery: bad to the bone, part 1. Integr Med (Encinitas) 2016;15:48–54. [PMC free article] [PubMed] [Google Scholar]
  • 23.Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005;15:145–54. 10.1381/0960892053268264 [DOI] [PubMed] [Google Scholar]
  • 24.Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992;215:387–95. 10.1097/00000658-199204000-00014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004;8:48–55. 10.1016/j.gassur.2003.09.020 [DOI] [PubMed] [Google Scholar]
  • 26.Chang CG, Adams-Huet B, Provost DA. Acute post-gastric reduction surgery (APGARS) neuropathy. Obes Surg 2004;14:182–9. 10.1381/096089204322857537 [DOI] [PubMed] [Google Scholar]
  • 27.Parrott J, Frank L, Rabena R, et al. American society for metabolic and bariatric surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surg Obes Relat Dis 2017;13:727–41. 10.1016/j.soard.2016.12.018 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES